The Intelligence from The Economist
Wary pharma: AstraZeneca sours on UK
AstraZeneca has paused a significant investment in the UK, potentially impacting the country's life-science sector. The episode also covers autonomous air wings and coral reef restoration efforts in the Caribbean.